Provide search filter criteria
Authors | Title | Year | Citation |
---|---|---|---|
Online updating of statistical inference in the big data setting. | 2016 | Technometrics. 2016;58(3):393-403. Pub Med | |
Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data. | 2016 | BMC Med Res Methodol. 2016;16(1):122. Pub Med | |
Support vector hazards machine: A counting process framework for learning risk scores for censored outcomes. | 2016 | J Mach Learn Res. 2016;17():. Pub Med | |
Joint structure selection and estimation in the time-varying coefficient Cox model. | 2016 | Stat Sin. 2016;26(2):547-567. Pub Med | |
Outcome-dependent sampling design and inference for Cox's proportional hazards model. | 2016 | J Stat Plan Inference. 2016;178():24-36. Pub Med | |
Posterior contraction rates of the phylogenetic Indian buffet processes. | 2016 | Bayesian Anal. 2016;11(2):477-497. Pub Med | |
Asymptotically normal and efficient estimation of covariate-adjusted Gaussian graphical model. | 2016 | J Am Stat Assoc. 2016;111(513):394-406. Pub Med | |
Rare variants association analysis in large-scale sequencing studies at the single locus level. | 2016 | PLoS Comput Biol. 2016;12(6):e1004993. Pub Med | |
Maximum likelihood estimation for semiparametric transformation models with interval-censored data. | 2016 | Biometrika. 2016;103(2):253-271. Pub Med | |
Learning optimal individualized treatment rules from electronic health record data. | 2016 | IEEE Int Conf Healthc Inform. 2016;2016():65-71. Pub Med | |
SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling. | 2017 | Genome Biol. 2017;18(1):66. Pub Med | |
Selection of the initial design for the two-stage continual reassessment method. | 2017 | J Biopharm Stat. 2017;27(3):495-506. Pub Med | |
Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result? | 2017 | J Biopharm Stat. 2017;27(3):457-476. Pub Med | |
Proportional hazards model with a change point for clustered event data. | 2017 | Biometrics. 2017;73(3):835-845. Pub Med | |
Efficient estimation of semiparametric transformation models for the cumulative incidence of competing risks. | 2017 | J R Stat Soc Series B Stat Methodol. 2017;79(2):573-587. Pub Med | |
Bayesian model assessment in joint modeling of longitudinal and survival data with applications to cancer clinical trials. | 2017 | J Comput Graph Stat. 2017;26(1):121-133. Pub Med | |
Semiparametric regression analysis of interval-censored competing risks data. | 2017 | Biometrics. 2017;73(3):857-865. Pub Med | |
PreMeta: A tool to facilitate meta-analysis of rare-variant associations. | 2017 | BMC Genomics. 2017;18(1):160. Pub Med | |
Dose-finding designs for trials of molecularly targeted agents and immunotherapies. | 2017 | J Biopharm Stat. 2017;27(3):477-494. Pub Med | |
Improving efficiency of parameter estimation in case-cohort studies with multivariate failure time data. | 2017 | Biometrics. 2017;73(3):1042-1052. Pub Med | |
SR-HARDI: Spatially regularizing high angular resolution diffusion imaging. | 2016 | J Comput Graph Stat. 2016;25(4):1195-1211. Pub Med | |
Ten simple rules for effective statistical practice. | 2016 | PLoS Comput Biol. 2016;12(6):e1004961. Pub Med | |
Personalized dose finding using outcome weighted learning. | 2016 | J Am Stat Assoc. 2016;111(516):1509-1521. Pub Med | |
Quantifying the impact of non-coding variants on transcription factor-DNA binding. | 2017 | Res Comput Mol Biol. 2017;10229():336-352. Pub Med | |
Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. | 2017 | Cancer Discov. 2017;7(10):1116-1135. Pub Med | |
Principal components adjusted variable screening. | 2017 | Comput Stat Data Anal. 2017;110():134-144. Pub Med | |
Dynamic treatment regimes, past, present, and future: A conversation with experts. | 2017 | Stat Methods Med Res. 2017;26(4):1605-1610. Pub Med | |
Reporting and guidelines in propensity score analysis: A systematic review of cancer and cancer surgical studies. | 2017 | J Natl Cancer Inst. 2017;109(8):. Pub Med | |
Validation of progression-free survival as a surrogate endpoint for overall survival in malignant mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials. | 2017 | Oncologist. 2017;22(2):189-198. Pub Med | |
Survival benefit of lung transplantation in the modern era of lung allocation. | 2017 | Ann Am Thorac Soc. 2017;14(2):172-181. Pub Med | |
Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012. | 2016 | J Clin Oncol. 2016;34(33):3992-3999. Pub Med | |
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome. | 2016 | Eur Heart J. 2016;37(4):412-22. Pub Med | |
Translational Breast Cancer Research Consortium (TBCRC) 022: A phase II trial of Neratinib for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases. | 2016 | J Clin Oncol. 2016;34(9):945-52. Pub Med | |
A comparison of proposed biosimilar LA-EP2006 and reference Pegfilgrastim for the prevention of neutropenia in patients with early-stage breast cancer receiving Myelosuppressive adjuvant or Neoadjuvant chemotherapy: Pegfilgrastim Randomized Oncology (Supp | 2016 | Oncologist. 2016;21(7):789-94. Pub Med | |
Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer. | 2016 | Future Oncol. 2016;12(11):1359-67. Pub Med | |
Embracing rejection: Immunologic trends in brain metastasis. | 2016 | Oncoimmunology. 2016;5(7):e1172153. Pub Med | |
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. | 2016 | Sci Transl Med. 2016;8(369):369ra175. Pub Med | |
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR(+), HER2(-) breast cancer that had progressed during or after prior endocrine therapy. | 2017 | Breast Cancer Res. 2017;19(1):18. Pub Med | |
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. | 2017 | Lancet Oncol. 2017;18(6):732-742. Pub Med | |
Maximum likelihood estimation for stochastic volatility in mean models with heavy-tailed distributions. | 2017 | Appl Stoch Models Bus Ind. 2017;33(4):394-408. Pub Med | |
Incorporating patient preferences into estimation of optimal individualized treatment rules. | 2018 | Biometrics. 2018;74(1):18-26. Pub Med | |
Reweighted estimators for additive hazard model with censoring indicators missing at random. | 2018 | Lifetime Data Anal. 2018;24(2):224-249. Pub Med | |
Change-plane analysis for subgroup detection and sample size calculation. | 2017 | J Am Stat Assoc. 2017;112(518):769-778. Pub Med | |
On estimation of optimal treatment regimes for maximizing t-year survival probability. | 2017 | J R Stat Soc Series B Stat Methodol. 2017;79(4):1165-1185. Pub Med | |
Design of phase II non-inferiority trials. | 2017 | Contemp Clin Trials Commun. 2017;7():23-27. Pub Med | |
Subgroup detection and sample size calculation with proportional hazards regression for survival data. | 2017 | Stat Med. 2017;36(29):4646-4659. Pub Med | |
Interactive Q-learning for quantiles. | 2017 | J Am Stat Assoc. 2017;112(518):638-649. Pub Med | |
A regularized variable selection procedure in additive hazards model with stratified case-cohort design. | 2018 | Lifetime Data Anal. 2018;24(3):443-463. Pub Med | |
Static and dynamic DNA loops form AP-1-bound activation hubs during macrophage development. | 2017 | Mol Cell. 2017;67(6):1037-1048.e6. Pub Med | |
Robust learning for optimal treatment decision with NP-dimensionality. | 2016 | Electron J Stat. 2016;10():2894-2921. Pub Med |